FI952629A - Kefiksiimivalmiste - Google Patents

Kefiksiimivalmiste Download PDF

Info

Publication number
FI952629A
FI952629A FI952629A FI952629A FI952629A FI 952629 A FI952629 A FI 952629A FI 952629 A FI952629 A FI 952629A FI 952629 A FI952629 A FI 952629A FI 952629 A FI952629 A FI 952629A
Authority
FI
Finland
Prior art keywords
micron
max
particles
suspensions
diameter
Prior art date
Application number
FI952629A
Other languages
English (en)
Swedish (sv)
Other versions
FI952629A0 (fi
Inventor
Joachim Bolz
Gertraud Wagner
Eckhard Oelrich
Dirk Radtke
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of FI952629A0 publication Critical patent/FI952629A0/fi
Publication of FI952629A publication Critical patent/FI952629A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI952629A 1994-05-31 1995-05-30 Kefiksiimivalmiste FI952629A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4418957A DE4418957A1 (de) 1994-05-31 1994-05-31 Cefixim-Zubereitung

Publications (2)

Publication Number Publication Date
FI952629A0 FI952629A0 (fi) 1995-05-30
FI952629A true FI952629A (fi) 1995-12-01

Family

ID=6519407

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952629A FI952629A (fi) 1994-05-31 1995-05-30 Kefiksiimivalmiste

Country Status (25)

Country Link
US (1) US5776926A (fi)
EP (1) EP0685232B1 (fi)
JP (1) JPH07330607A (fi)
KR (1) KR950031077A (fi)
CN (1) CN1117383A (fi)
AT (1) ATE190844T1 (fi)
AU (1) AU694201B2 (fi)
CA (1) CA2150442A1 (fi)
CO (1) CO4410174A1 (fi)
CZ (1) CZ138595A3 (fi)
DE (2) DE4418957A1 (fi)
DK (1) DK0685232T3 (fi)
ES (1) ES2146265T3 (fi)
FI (1) FI952629A (fi)
GR (1) GR3033704T3 (fi)
HU (1) HU218217B (fi)
IL (1) IL113917A0 (fi)
NO (1) NO952138L (fi)
NZ (1) NZ272216A (fi)
PE (1) PE18796A1 (fi)
PL (1) PL308838A1 (fi)
PT (1) PT685232E (fi)
SK (1) SK72795A3 (fi)
TW (1) TW301610B (fi)
ZA (1) ZA954427B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0890359T3 (da) * 1996-02-29 2002-07-01 Fujisawa Pharmaceutical Co Beta-Lactam-antibiotikumholdige tabletter og fremgangsmåde til fremstilling deraf
TW200404550A (en) * 2002-07-08 2004-04-01 Sankyo Co Cepharospolin formulation for oral use
WO2005107703A1 (en) * 2004-05-10 2005-11-17 Lupin Ltd. Novel pharmaceutical formulation of cefixime for enhanced bioavailability
US9233112B2 (en) 2006-04-13 2016-01-12 Lupin Limited Pharmaceutical compositions of cefixime
US9241905B2 (en) 2006-04-13 2016-01-26 Lupin Limited Pharmaceutical compositions of Cefixime
CN103301068B (zh) * 2013-07-08 2014-09-10 广东彼迪药业有限公司 一种头孢克肟干混悬剂剂及其制备方法
JP6449873B2 (ja) * 2013-07-18 2019-01-09 サンド・アクチエンゲゼルシヤフト 抗生物質のドライシロップ製剤用の粉末混合物
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11173163B2 (en) * 2015-08-05 2021-11-16 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same
US11446236B2 (en) 2015-08-05 2022-09-20 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996355A (en) 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
DE3804841A1 (de) * 1988-02-17 1989-08-31 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
US5409917A (en) * 1991-03-05 1995-04-25 Marvin S. Towsend Topical treatment of acne with cephalosporins

Also Published As

Publication number Publication date
CA2150442A1 (en) 1995-12-01
HU218217B (hu) 2000-06-28
AU2033595A (en) 1995-12-07
IL113917A0 (en) 1995-08-31
EP0685232A2 (de) 1995-12-06
DE4418957A1 (de) 1995-12-07
CZ138595A3 (en) 1996-04-17
JPH07330607A (ja) 1995-12-19
US5776926A (en) 1998-07-07
TW301610B (fi) 1997-04-01
NO952138L (no) 1995-12-01
PL308838A1 (en) 1995-12-11
PT685232E (pt) 2000-08-31
PE18796A1 (es) 1996-06-04
AU694201B2 (en) 1998-07-16
EP0685232A3 (de) 1996-05-08
NO952138D0 (no) 1995-05-30
HU9501570D0 (en) 1995-07-28
FI952629A0 (fi) 1995-05-30
CN1117383A (zh) 1996-02-28
CO4410174A1 (es) 1997-01-09
GR3033704T3 (en) 2000-10-31
ES2146265T3 (es) 2000-08-01
SK72795A3 (en) 1996-01-10
EP0685232B1 (de) 2000-03-22
HUT74421A (en) 1996-12-30
ZA954427B (en) 1996-01-24
KR950031077A (ko) 1995-12-18
NZ272216A (en) 1996-05-28
ATE190844T1 (de) 2000-04-15
DK0685232T3 (da) 2000-08-21
DE59508024D1 (de) 2000-04-27

Similar Documents

Publication Publication Date Title
IT1267391B1 (it) Procedimento per l'assemblaggio di una batteria bipolare piombo-acido e batteria bipolare ottenuta con tale procedimento.
ATE132115T1 (de) Verstärkte fällungskieselsäure
HK1089387A1 (en) Estrogenic compounds as antimitotic agents
TW349849B (en) Xanthan gelling agents
CA2125274A1 (en) Drilling mud additive
CA2151967A1 (en) Magnetic nanocomposite compositions and processes for the preparation and use thereof
NO952138D0 (no) Cefiximpreparat
AU3228689A (en) New 2,3,4 - substituted imidazoles and 3,4,5 - substituted 1,2,4, - triazoles, the preparation and use thereof
USD304057S (en) Exercise rod
IL99501A0 (en) Interleukin 9 receptors,methods for the use thereof and pharmaceutical compositions containing the same
HUT41230A (en) Pesticide compositions containing substituted 4,5-dihydro-1,3,4-thiadiazol derivatives as active agents and process for producing the active agents
WO2000037546A3 (de) Expandierte polypropylen-partikel
USD283396S (en) Bottle
USD280401S (en) Terminal pin
DE3863687D1 (de) Tinten-zusammensetzungen und deren zubereitung.
USD282495S (en) Bellows unit for aspirator or resuscitator for newborn animals
DE3676256D1 (de) 3',4'-dideoxy-3'-fluorkanamycin b und dessen herstellung.
FI945645A0 (fi) Flegmatisoitu räjähdysaine
EP0276823A3 (en) 14,15-substituted lanosterols and their use as hypocholesterolemic agents
DE3872764D1 (de) Tinten-zusammensetzungen und deren zubereitung.
DE69820098D1 (de) Diamantpartikel, bestehend aus einem diamantenem kern und einem diamantenem überzug
AU3322589A (en) Lubricant
AU587293B2 (en) 5-heterocyclic-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants
AU9541898A (en) Azines containing the 5,6-di-hydro-(1,4,2) dioxazine-3-yl group and the use thereof as fungicides
FR2575070B3 (fr) Composition a effet assainissant, en particulier pour le parfumage d'air ambiant